Global X Genomics & Biotechnology UCITS ETF (LON:GNOG)

Assets	95.66M
Expense Ratio	0.50%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+86.05%

Volume	25,318
Open	9.27
Previous Close	9.27
Day's Range	9.22 - 9.37
52-Week Low	4.84
52-Week High	9.35
Beta	0.78
Holdings	52
Inception Date	Nov 2, 2021

About GNOG

The Global X Genomics & Biotechnology UCITS ETF (GNOM LN) is designed to replicate the overall financial performance of the Solactive Genomics v2 Index. This includes mirroring both the index's price movements and its income generation, prior to the deduction of fund fees and operating expenses.

• Asset Class: Equity
• Category: Theme
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GNOG
• Provider: Global X
• Index Tracked: Solactive Genomics v2 Index - Benchmark TR Net

Performance

GNOG had a total return of 86.05% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.54%.

Top 10 Holdings

52.64% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	7.98%
Twist Bioscience Corporation	TWST	7.39%
10x Genomics, Inc.	TXG	6.53%
Guardant Health, Inc.	GH	5.76%
Illumina, Inc.	ILMN	5.27%
Natera, Inc.	NTRA	5.12%
Genscript Biotech Corporation	1548	4.29%
Bio-Techne Corporation	TECH	3.55%
BioMarin Pharmaceutical Inc.	BMRN	3.40%
Vertex Pharmaceuticals Incorporated	VRTX	3.35%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error